Selective Serotonin Reuptake Inhibitor
Fluoxetine for Anxiety and Depression
Recruiting0 awardsPhase 2
Bethesda, Maryland
This trial uses fMRI to study brain regions engaged in processing motivationally salient stimuli in children, adolescents, and adults with mood and anxiety disorders, in order to better understand how these disorders develop and how they can be treated.
Anti-metabolites
Decitabine for Myelofibrosis
Recruiting1 awardPhase 2
Baltimore, Maryland
This trial looks at the side effects and effectiveness of decitabine in treating patients with myelofibrosis, a cancer of the blood system. Decitabine may block proteins that turn certain genes off in various cancers including myelofibrosis.
Virus Therapy
Virotherapy for Castleman Disease
Recruiting1 awardPhase 2
Bethesda, Maryland
This trial is studying a rare disorder caused by the Kaposi's sarcoma herpes virus (KSHV), which also causes several types of cancer. Researchers want to understand the biology of KSHV-associated multicentric Castleman's disease (MCD) to find ways to treat it.
Popular Filters
Phase 3 Trials
Alkylating agents
Chemotherapy + Monoclonal Antibody Therapy for Non-Hodgkin's Lymphoma
Recruiting4 awardsPhase 3
Washington, District of Columbia
This trial is comparing two different ways of treating non-Hodgkin's lymphoma with chemotherapy, using either one monoclonal antibody or two monoclonal antibodies.
Immunomodulatory Agent
Lenalidomide + Dexamethasone +/- Thalidomide for Multiple Myeloma
Recruiting2 awardsPhase 3
Baltimore, Maryland
This trial tests if lenalidomide with either standard or low-dose dexamethasone works better for new multiple myeloma patients. If not, thalidomide is added. The goal is to find effective treatments with fewer side effects. Lenalidomide plus low-dose dexamethasone has been shown to be an effective treatment for multiple myeloma, particularly in patients who are not candidates for stem cell transplantation.
Radiation
Radiation + Chemotherapy for Medulloblastoma
Recruiting2 awardsPhase 3
Baltimore, Maryland
This trial is looking at whether standard-dose radiation therapy, versus reduced-dose, is more effective in children 3-7 years of age who have had surgery for newly diagnosed standard-risk medulloblastoma.
Trials With No Placebo
Tyrosine Kinase Inhibitor
Tyrosine Kinase Inhibitors for Hypereosinophilic Syndrome
Recruiting1 awardPhase 2
Bethesda, Maryland
This trial is for patients with a rare blood disorder called hypereosinophilic syndrome, who have not responded to standard treatment. The study will test whether the drug imatinib mesylate (Gleevec) is safe and effective in reducing blood eosinophils in these patients.
Alkylating agents
Chemotherapy + Monoclonal Antibody Therapy for Non-Hodgkin's Lymphoma
Recruiting4 awardsPhase 3
Washington, District of Columbia
This trial is comparing two different ways of treating non-Hodgkin's lymphoma with chemotherapy, using either one monoclonal antibody or two monoclonal antibodies.
Diagnostic Imaging for Pheochromocytoma
Recruiting1 awardPhase 1
Bethesda, Maryland
This trial is testing better methods to detect, locate, and treat pheochromocytomas. These are tumors that usually form in the adrenal glands and can cause high blood pressure. They can be hard to detect with current methods and can lead to severe medical consequences if left undetected.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.